METHODS FOR DIAGNOSING AND INDUCING LEUKAEMIA/LYMPHOMA Russian patent published in 2016 - IPC G01N33/574 G01N33/53 G01N33/58 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely a diagnostic technique for acute lymphoblastic leukaemia in a patient involving detection of leukaemia indicators, blood cell testing for leukaemia, blood cell incubation with a leukaemia inducing factor to induce expression of cell surface markers which are a leukaemia indicator, wherein the leukaemia inducing factor is Aspergillus flavus supernatant, EBV-infected CCL87 supernatant, purified EBV culture or a combination thereof. The blood cell testing for cell surface markers, wherein the level of cell surface markers is the leukaemia indicator, or blood plasma testing for leukaemia. Incubation with leukaemia inducing factor in a tray with leukaemia inducing factor, blood plasma incubation with leukaemia inducing factor. Blood plasma immune-sorbent assay and IgG responsiveness measurement in biological samples, wherein IgG responsiveness is the leukaemia indicator. A method for introducing leukaemia inducing factor into mononuclear cells.

EFFECT: using the declared methods enables diagnosing and detecting acute lymphoblastic leukaemia in the patients effectively.

14 cl, 24 dwg, 4 ex